This study is for patients with advanced lymphoid malignancies, which are types of blood cancers affecting white blood cells. It will test a new treatment called BP1002 to see how safe and effective it is. The study involves 12 patients who have cancers like Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, and others. Patients must be adults who have tried other treatments without success. They should have at least a 3-month life expectancy.
Key Points:- The study will have multiple visits, so patients need to be available for several appointments.
- No direct compensation is mentioned, but participants may benefit from the new treatment.
- There are risks, such as side effects from the treatment, which will be explained by the doctor.
To join, patients must not have other active cancers or infections, and they need to use contraception if they are of childbearing potential. They should also be in good general health, except for their cancer. Patients will need to sign a consent form to participate.
How understandable was the trial content above?
Hard to understand
Easy to understand